KAKETSUKEN has its origin in the "Institute of Experimental Medicine" which was established on the premises of Kumamoto Medical College in 1926. KAKETSUKEN was founded to produce and supply vaccines, antiserums, and diagnostic antigens in 1945. KAKETSUKEN's research and development theme is to: "Make use of biological elements for the prevention and treatment of more diseases." To realize this theme, the company's technology is fostered through vaccines and blood plasma products, as well as peripheral technology from its completely equipped experimental facilities of the Good Laboratory Practice (GLP), and experimental animal models. KAKETSUKEN are confident that their efforts will help improve preventive medicine as well as health and hygiene, which in turn will lead to solutions to various problems.